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Altered glomerular permeability induced by F(ab')2 and Fab' antibod-
ies to rat renal tubular epithelial antigen. Rats injected with F(ab')2 and
Fab' antibody fragments directed against an antigen in the rat proximal
tubular epithelial brushborder (FxIA) developed immediate proteinuria
[F(ab')2 43.2 6.7, N 6; Fab' 9.5 2.8, N = 5; normal 1.6 0.9 mg/
day, N = 20]), that subsided after 3 to 5 days' duration. This reaction is
in contrast to one exhibited by rats given intact IgG anti-FxIA; the rats
that did not develop immediate proteinuria (2.2 0.3 mg/day, N = 5),
and the glomerular binding of '251-antibody fragments was significantly
less than that of intact igG [F(ab')2 0.11 0.01; Fab' 0.03 0.01; lgG
0.17 0.01% administered equimolar dose] at 24 hr. No proteinuria
resulted from equimolar doses of nonantibody F(ab')0 and Fab'. Less
than 8% of the proteinuria induced by antibody fragments represented
injected material, and 30 to 38% was albumin. lmmunofluorescence
revealed faint and diffuse glomerular capillary wall deposits of F(ab')2
and Fab' and tubular brushborder staining. Subepithelial, electron-
dense deposits and focal, podocyte effacement were seen by electron
microscopy in rats given the F(ab')2 antibody. Light microscopy and
colloidal iron-staining were normal, in our study antibody fragments
appear to interact directly with components of the outer, glomerular
capillary wall to alter permeability in the absence of recognized
mediators such as complement and inflammatory cells.
Modification de Ia perméabilité glomerulaire déterminée par anticorps
chez des rats anti-épithélium tubulaire F(ab')2 et Fab'. Les rats été
injectés avec des fragments F(ab')2 et Fab' contra anticorps de Ia
bordure en brosse de l'épithélium tubulaire proximal de rat (FxIA) ant
immediatement une protéinurie [F(ab')2 43,2 6,7, N = 6; Fab' 9,5
2,8, N = 5; normaux 1,6 0,9 mg/d, N = 20] qui persiste pendant 3 aSjours. Cela reaction est different de cc qui est observe chez les rats qui
reçoivent l'IgG anti-FxIA intacte; les rats quelles n'ont pas de protein-
uric immediate (2,2 0,3 mg/d, N = 5) quoiqu'h 24 heures Ia liaison
glomérulaire de fragments 251 de l'anticorps soit significativement plus
faible que celle de I'lgG intacte [F(ab')2 0,11 0,01; Fab' 0,03 0,01;
igG 0,17 0,01 en % de Ia dose equimolaire administrée]. Aucune
protéinurie n'a étë Ia consequence de l'administration équimolaire de
F(ab')2 et Fab' non-anticorps. Moms de 8% de Ia protéinurie deter-
minée par les fragments d'anticorps reprCsentent du materiel injecté et
30 a 38% est de l'albumine. L'immunofluorescence a montré des dépôts
faibles et diffus, sur les parois des capillaires glomerulaires, de F(ab')2
et Fab' et le marquage de Ia bordure en brosse. En electronique, des
dépôts denses sous-epithéliaux et l'effacement local des podocytes ont
été observes chez les rats qui avaient recu l'anticorps F(ab')2. La
microscopic optique et Ia coloration par Ic fer colloidal n'ont pas montré
d'anomalies. Dans notre étude les fragments d'anticorps semblent avoir
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paroi externe du capillaire glomérulaire et avoir modiflé Ia permeabilité
en l'absence de médiateurs connus tels le complement ou les cellules
inflammatoires.
Proteinuria is the major glomerular, functional alteration
which results from the deposition of immune reactants of
various types in glomeruli. Antibodies may form deposits in
glomeruli by binding to constituents of the glomerular basement
membrane (GBM) [1], by passive entrapment in the form of
circulating complexes containing antibody and either endoge-
nous or exogenous antigens [1], or by the formation of such
complexes within glomeruli [2]. Studies of these glomerular
disease types in experimental models have identified several
different processes by which immune deposits may mediate an
increase in glomerular permeability. Thus, proteinuria may be
dependent on complement fixation and the action of infiltrating
neutrophils as in the classical studies of the heterologous phase
of nephrotoxic nephritis induced by anti-GBM antibodies [3, 4].
It may be independent of complement but dependent on neutro-
phils, as in the autologous phase of certain forms of nephrotoxic
nephritis [5, 6], or dependent upon the fixation of complement
but not on the presence of neutrophils in the heterologous phase
of experimental membranous nephropathy [7]. In addition,
there are a number of experimental models in which neither
complement nor neutrophils are required for the development
of proteinuria [3, 8—101. In some models, mononuclear cells L1l,
12] have an important role, but in other models proteinuria
appears to depend on the action of the antibody alone [13].
During our studies of the mechanisms of subepithelial im-
mune deposit formation [14] and proteinuria [7] in passive
Heymann nephritis (PHN), an experimental model of membra-
nous nephropathy which is induced in rats by a heterologous
antibody to the proximal, tubular, epithelial, cell brush border
(FxlA), we noted that the rats given F(ab')2 fragments of anti-
FxIA IgG developed immediate and transient proteinuria with-
out complement fixation [15]. This finding was in contrast to the
proteinuria induced either by the native anti-FxIA antiserum or
by anti-Fx1A IgG which appeared only after 4 to 5 days and was
shown to be complement-dependent [7]. Our report confirms
and extends those observations providing additional evidence
that the interaction of the antibody alone with certain compo-
nents of the glomerular filter, in the absence of complement-
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fixation or neutrophil infiltration, can alter glomerular perme-
ability.
Methods
Production of anti-rat FxIA and isolation and characteriza-
tion of IgG, F(ab')2, and Fab' fragments. Sheep were hyperim-
munized with 3 to 4 monthly injections of 75 to 100 mg of rat
FxlA which was prepared as described by Edgington, Glass-
ock, and Dixon [161 and emulsified in complete Freund's
adjuvant (Difco Laboratories, Detroit, Michigan, USA). The
IgG antibody was isolated by ion-exchange chromatography
from a 50% ammonium sulphate precipitate of heat-inactivated
(56° C, 30 mm), whole sheep serum absorbed with rat serum,
red cells, white cells, and platelets as previously described [7].
The IgG was eluted from a DEAE-Sephacel® (Pharmacia Fine
Chemicals, Piscataway, New Jersey, USA) column using
0.0175 M sodium phosphate, starting buffer, pH 7.4, and a linear
sodium chloride gradient to 0.3 M. The 2 major IgG peaks were
pooled, concentrated in an Amicon® PM3O ultrafilter (Amicon
Corporation, Scientific Systems Division, Lexington, Massa-
chusetts, USA) to approximately 10 mg/mI and stored at —70° C
before use.
F(ab')2 fragments were prepared from IgG, isolated as de-
scribed above, by digestion with pepsin according to the
method of Nisonoff et a! [17]. Approximately 100 mg IgG, at a
concentration of 10 to 20 mg/mI was incubated with pepsin
(crystalized twice, Sigma Biochemical Corporation, Freehold,
New Jersey, USA) at a protein: enzyme ratio of 100:1 in 0.2 M
acetate buffer, pH 4.5 at 37° C for 18 hr. Fab' fragments were
produced by duplication of this procedure with the addition of
0.01 M cysteine hydrochloride (Fisher Scientific Company, Fair
Lawn, New Jersey, USA) to the mixture. Digestion and reduc-
tion were terminated by raising the pH to 8.0 with 1.0 N sodium
hydroxide. F(ab')2 and Fab' fragments were separated from
undigested IgG (< 10% of the total protein) and smaller
fragments by gel filtration chromatography on Sephadex® G-
150 (Pharmacia). Samples of 30 to 50 mg in 1.5 ml were applied
to a size calibrated 1.5 x 90 cm column and eluted with 0.01 M
sodium phosphate and 0.2 M sodium chloride buffer, pH 8.2.
The F(ab')2 and Fab' peaks were concentrated to about 10 mg/
ml, dialysed against a phosphate-buffered saline, pH 7.2 (PBS),
and stored at —70° C until used. The molecular size of sheep
IgG (160,000 daltons), F(ab')2 fragments (96,000 daltons), and
Fab' fragments (48,000 daltons) was calculated from the elution
volumes from the Sephadex® G-150 column.
In addition to the chromatographic elution profile [obtained
in preparing IgG, F(ab')2, and Fab' fragments], the following
procedures were performed to further characterize each rea-
gent. Purity was assessed by immunoelectrophoresis against
antiserum to whole sheep serum and to sheep IgG (Cappel
Laboratories Inc., Cochranville, Pennsylvania, USA) [18], and
specificity was determined by micro-Ouchterlony in 1% agarose
against whole rat serum and a 10 mg/ml suspension ofFxIA in a
saline [19]. Antibody reactivity in vitro with glomeruli and
proximal tubular brushborders was determined as described
below, by indirect immunofluorescence (IF) on cryostat sec-
tions of normal kidneys stained with the fluorescein-conjugat-
ed, IgG fraction of rabbit antiserum to sheep IgG (heavy and
light chains, Cappel Laboratories, Cochranville, Pennsylvania)
[20, 21]. The rabbit antiserum to sheep IgG was monospecific
for sheep IgG as demonstrated by immunoelectrophoresis
against whole sheep serum and sheep IgG. The in vitro comple-
ment-fixing ability was assessed by an indirect IF technique as
described below.
Normal sheep IgG, F(ab')2, and Fab' fragments were pre-
pared from normal sheep serum exactly as described above for
antiserum to FxlA. Protein concentrations of purified prepara-
tions of sheep IgG and IgG fragments were measured by the
Biuret method.
Experimental design. Male Charles River CD® rats (Charles
River Breeding Laboratories, Wilmington, Massachusetts,
USA) weighing 130 to 200 g were allocated to 6 groups and
given a single intravenous injection of the following prepara-
tions: (1) anti-FxlA IgG, 10 mg (N = 5); (2) anti-FxlA F(ab')2,
30 mg (N 6); (3) anti-FxlA Fab', 15 mg (N = 5); (4)
nonantibody sheep IgG, 10 mg (N = 4);(5) nonantibody F(ab')2,
30mg (N = 3); (6) nonantibody Fab', 15 mg (N = 3). A separate
group of 8 rats was depleted of the complement (C3) with the
purified, cobra venom factor (Cordis Laboratories, Miami,
Florida, USA), 300 U/kg, in 4 divided doses as previously
described [7], starting 24 hr before the intravenous injection of
30 mg (N = 3) and 50 mg (N = 3). These doses were chosen to
determine whether antibody IgG (in the absence of the comple-
ment) had the same effect as the F(ab')2 antibody when given in
equal weight (30 mg) or equimolar amount (50 mg). Urine
samples were collected in individual metabolic cages for a 24-hr
measurement of protein excretion beginning 4 hr after the
injection of the various preparations and 3 days later in those
groups in which proteinuria was found. Renal biopsies were
obtained under ether anesthesia for light, IF, and electron
microscopy from 2 rats in each group after 4 hr and from all rats
24 hr after the injection.
Quantitative measurements of in vivo glomerular binding of
the different reagents were made by injecting trace amounts of
the '251-labeled antibody and nonantibody IgG and their respec-
tive F(ab')2 and Fab' fragments into separate groups of age-
matched rats and sacrificing them after 24 hr. The number of
rats injected with each labeled reagent is shown in the Results
section. Radioiodination was performed with the chloramine—
T method [22] which produced labeled preparations with specif-
ic activities of 0.5 x 106 to 2.0 x 106 cpm/mg of protein of which
89 to 95% was precipitable with 10% trichloroacetic acid. A
detailed account of the methods used to measure glomerular
binding of radiolabeled anti-Fx1A and normal sheep IgG has
been published [23]. In our study, glomerular binding was
measured from the activity of glomeruli isolated from saline-
perfused whole kidneys obtained just prior to the sacrifice of
each rat 24 hr after the injection of the labeled preparations.
Glomeruli from the kidneys of each rat were isolated by sieving
techniques as described elsewhere [21]. The results are ex-
pressed as a percentage of the administered dose.
To determine whether the early proteinuria which develops in
rats given the F(ab')2 antibody could be accounted for by
excretion of injected material, we gave 9 rats 20 to 40 mg of the
F(ab')2 antibody trace-labeled with 1251. Urine samples were
collected for a 24-hr measurement of the total protein excretion
from day 1 to 2 postinjection, and F(ab')2 content was calculat-
ed from the trichloroacetic acid-precipitable radioactivity in the
urine samples. Total protein content was measured by a sulfo-
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Nb 0—1 1—2 3—4 4—5
Norma! rats
Anti-FxI A
IgG, 10mg 5 2.2 0.3 4.5 2.1
F(ab'),, 30mg 6 43.2 6.7 5,3 1.6
Fab', 15 mg 5 9.5 2.8° 2.9 1.0
Nonantibody
IgG, 45mg 5 1.9 1.3 3.5 1.1
F(ab')2, 30 mg 3 2.6 0.7
Fab', 15 mg 3 0.9 0.3
Anti-Fx IA
'251-F(ab')2, 20mg 6 7.9 1.5° 3.4 1.1
'251-F(ab')2, 40mg 3 17.9 8.0° 4.7 1.7
F(ab')2, 25 mg 1 43.0
Complement-depleted rats
Anti-Fx IA
F(ab'),, 30 mg 3 63.0 16.0°
IgG,3Omg 3 1.1 0.3
IgG, 50mg 2 1.5 and 3.3
a Values are means SD.
N represents the number of rats studied.
Value significantly different from nonantibody controls and from 20 normal age-matched rats (1.6 0.9 mg/24 hr) with P < 0.001.
Abbreviations used are defined as: FxIA, proximal tubular epithelial cell brushborder antigen.
salicylic acid method [23] using a commercially prepared whole
serum standard (Lab-Trol, Dade Diagnostics Inc., Miami, Flor-
ida, USA). The urine protein composition of samples concen-
trated 20-fold was determined by agarose gel electrophoresis
and densitometry [10].
Tissue processing and IF procedures. Biopsies of the kidneys
were obtained under ether anesthesia or at sacrifice and were
processed for light microscopy, IF, and electron microscopy as
previously described in detail [24]. Tissue was fixed in a 10%
neutral formalin, sectioned at 2 p., stained with periodic acid-
Schiff reagent, and examined for glomerular and other histologi-
cal changes.
Direct and indirect IF procedures were performed on tissue
snap-frozen in dry ice-isopentane. Cryostat sections were fixed
in ether-alcohol and stained using techniques and controls
described previously [20, 24]. All biopsies were stained with the
IgG fractions of monospecific antisera to sheep IgG and rat IgG,
C3, and albumin (Cappel Laboratories) which had been conju-
gated with fiuorescein isothiocyanate (Bioquest, BBL Falcon
Products, Division of Becton, Dickinson and Company, Cock-
eysville, Maryland, USA) by a dialysis method [25]. The
antibody to rat lgG was not cross-reactive with sheep IgG by
immunoprecipitin or IF analysis.
Washed, unfixed cryostat sections of normal rat kidneys,
previously incubated with the various anti-FxIA reagents, were
tested for an in vitro complement-fixing ability by incubating
them with the appropriate dilution of fresh or heat-inactivated
human serum in a veronal buffer at 20° C for 45 mm followed by
washing and staining for human C3 by direct IF using fluoresce-
in-conjugated antiserum to human C3 (Cappel Laboratories)
[10, 26]. Human, antinuclear, antibody-containing serum was
utilized as a positive control for the in vitro complement-
fixation procedures [26]. IF was evaluated and photographed on
a Leitz Ortholux II microscope equipped with a Ploempack®
2,2 vertical fluorescence illuminator (E. Leitz Inc., Rockleigh,
New Jersey, USA). Tissue for EM was immersion-fixed in
glutaraldehyde and post-fixed in osmium followed by en bloc
staining in uranyl acetate for 30 mm before embedding in Epon®
812.
Colloidal iron-staining for glomerular polyanion was per-
formed on snap-frozen tissue using methods previously de-
scribed in detail [24, 27].
Statistical analysis. An analysis of the variance was used to
analyze the results of urine protein excretion and glomerular
antibody binding when more than two groups were compared
[28]. The results of colloidal iron-staining were evaluated by the
Mann-Whitney U test for non-parametric data. Differences
were regarded as significant when P < 0.05. All values are
expressed as mean SD unless otherwise stated.
Results
Characteristics of anti-FxJA IgG, F(ab')2 and Fab'. Anti-
FxlA IgG, F(ab')2, and Fab' made a single arc of precipitation
in the same region as native sheep IgG by immunoelectrophore-
sis against antiserum to whole sheep serum and to sheep lgG.
Micro-Ouchterlony of IgG and F(ab')2 antibody revealed the
same three lines of reactivity against insoluble FxIA as previ-
ously reported [16, 20] and no reactivity against whole rat
serum. No precipitin lines were seen with the Fab' antibody on
micro-Ouchterlony against FxlA. By indirect IF, anti-FxIA
IgG, F(ab')2 and Fab' produced intense staining of the luminal
surface of proximal, tubular, epithelial cells in similar dilutions
(IgG 1:400; F(ab')2 1:400; Fab' 1:800), and faint, diffuse glomer-
ular staining for sheep IgG on sections of normal rat kidney.
When normal, rat kidney sections were first incubated with
anti-Fx1A IgG, F(ab')2 or Fab' to produce proximal, tubular,
epithelial brushborder deposits followed by incubation with
fresh or inactivated human serum and then stained for human
C3, the IgG antibody produced positive brushborder staining
with fresh but not inactivated serum. The F(ab')2 and Fab'
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Time after antibody injection, days
Fig. 1. Urine protein excretion over the course of 5 days in 3 groups of
rats given anti-FxIA F(ab')2, Fab', and IgG. Dashed horizontal line
indicates the upper 99% confidence limit of 20 normal age-matched rats.
Dashed bar represents the urine protein excretion on days 4—5 of 16 rats
given unfragmented anti-FxIA IgG as previously reported [7].
antibody fragments failed to produce brushborder staining for
C3 in both fresh and inactivated human serum. In control
studies, normal rat kidneys incubated with an antinuclear
antibody and fresh human serum showed positive nuclear
staining for human C3 while normal rat kidneys incubated with
fresh human serum without prior incubation with anti-Fx1A or
antinuclear antibody exhibited an absence of staining for C3.
Thus, the anti-FxIA IgG fixed complement in vitro, but the
antibody fragments did not.
Early onset proteinuria in anti-FxIA F(ab')2-and Fab' -inject-
ed rats. Table 1 shows urine protein excretion measured at
various times after the administration of different doses of intact
or fragmented antibody and nonantibody IgG to complement-
replete and complement-depleted rats. These results are illus-
trated graphically in Figure 1. In contrast to rats given intact
IgG antibody, those injected with F(ab')2 and Fab' antibody
fragments developed significant proteinuria within the first 24
hr (P < 0.001) which diminished after 3 days (Table 1, Fig. 1).
Control rats given intact and fragmented non-antibody IgG did
not become proteinuric (Table 1); the upper 99% confidence
limit of protein excretion in 20 normal age-matched rats was 3.5
mg/24 hr.
Rats depleted of serum C3 with the cobra venom factor to
less than 10% of pretreatment values became proteinuric during
the first 24 hr after an injection of 30 mg of anti-Fx1A F(ab')2
but not after an injection of an equal weight (30 mg) or
equimolar amount (50 mg) of an undigested IgG antibody with P
<0.001 (Table 1).
By agarose-gel electrophoresis and densitometry, the compo-
sition of urine protein excreted by F(ab')2, antibody-injected
rats during the first 24 hr was shown to be albumin 38%, a
globulin 32%, globulin 19%, and -y globulin 11%; and that
excreted by Fab' antibody injected rats was albumin 30%, a
globulin 43%, p globulin 20%, and -y globulin 7%. Urine protein
excreted by normal rats contained only 10.7% albumin and no -y
globulin. Most of the protein comprised a2—globulin with a
small amount of prealbumin. Measurement of the trichloroace-
tic acid-precipitable radioactivity in urine samples of 9 rats
injected with the F(ab')2 antibody which had been trace-labeled
with 125! demonstrated that only 5.5 1.6% of the protein
excreted (11.3 6.5 mg/24 hr) on day 1—2 was injected with
F(ab')2. In these 9 rats, protein excretion subsequently de-
creased and was less than 3.5 mg124 hr in all but 2 on day 4—5
_______
(3.8 1.4 mg/24 hr). This observation contrasts with our
previous findings (Fig. 1) using unfragmented anti-FxIA IgG in
rn which rats were found to develop proteinuria on day 4—5 [7, 29]
which was shown to be complement-dependent [7].
:1' IF, EM, and light microscopic findings. IF of biopsies from
rats given the IgG antibody exhibited diffuse, finely granular,
glomerular capillary wall deposits of sheep IgG at 3 hr, which
were more intense after 24 hr as previously reported [7, 29]. No
tubular epithelial staining was found. At 3 hr, glomeruli of rats
given the F(ab')2 and Fab' antibody showed diffuse staining for
sheep IgG which appeared to extend throughout the glomerular
capillary wall and was neither clearly granular nor linear. By 24
hr, numerous discrete, very finely granular, deposits of sheep
F(ab')2 were apparent on the glomerular capillary wall (Fig. 2).
Similar, but much fainter, deposits of sheep Fab' were seen
after 24 hr (Fig. 2). Intense fluorescence of the luminal surface
of proximal, tubular epithelial cells was seen at 3 and 24 hr in
biopsies of rats given F(ab')2 and Fab' antibody (Fig. 2).
Fluorescence stains for rat albumin, C3, and IgG were negative.
IF of biopsies from controls given nonantibody F(ab')2 and Fab'
were entirely negative. Electron microscopy at 3 and 24 hr
showed no abnormalities or deposits in tissue from control rats
or rats given unfragmented, antibody IgG. Biopsies obtained at
3 hr from rats given F(ab')2 and at 3 and 24 hr from those given
Fab' antibodies were normal by electron microscopy. Biopsies
obtained at 24 hr from rats which received the F(ab')2 antibody
showed many electron-dense deposits located exclusively in the
subepithelial space and focal areas of foot process effacement
(Fig. 3). There were no histologic abnormalities visible on light
microscopy of renal tissue obtained at 3 and 24 hr from rats
given either antibody or normal sheep IgG or their respective
F(ab')2 or Fab' fragments. In particular, glomeruli were devoid
of proliferative changes and infiltrating leucocytes. Colloidal
iron stains of 3 and 24 hr biopsies were normal and not different
in rats injected with antibody or non-antibody IgG and their
respective F(ab')2 and Fab' fragments.
Quantitative studies of glomerular antibody binding. Glomer-
uli isolated from perfused kidneys have been shown to be free
of unbound IgG [21]. In this study, glomeruli from rats given the
trace-labeled nonantibody F(ab')2 (N = 4) and Fab' (N = 4)
contained less than 0.003% of the administered dose of F(ab')2
and less than 0.0012% of the administered dose of Fab' after 24
hr. In some rats, glomerular radioactivity could not be distin-
guished from background activity. Antibody binding, measured
in glomeruli isolated from individual rats injected with equimo-
lar amounts of labeled anti-Fx1A IgG, F(ab')2 and Fab' was:
IgG 0.17 0.01% (N = 4); F(ab')2 0.11 0.01% (N = 4); Fab'
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Fig. 2. Immunofluorescent photomicro-
graphs 24 hr after an injection of anti-
FxIA F(ab')2 (A) and Fab' (B) stained for
sheep IgG. Glomerulat- capillary walls
show fine, granular deposits of F(ab')2
and fainter deposits of Fab'. Proximal
tubular epithelial cells stain brightly for
both F(ab')2 and Fab'. (Original magnifi-
cation, x 450)
Fig. 3. Electron micrograph 24 hr
after an injection of anti-FxIA
F(ab')2. The glomerular, capillary
wall contains numerous and small
subepithelial, electron-dense depos-
its (arrowheads) underlying focal ar-
eas of podocyte effacement. (Original
magnification, x 31,500)
Discussion
Antibody-induced proteinuria has been most extensively
studied during the heterologous phase of nephrotoxic nephritis
which is produced in various animals by antibodies to GBM
antigens and has been shown to be mediated largely by comple-
ment and to be dependent on the participation of neutrophils [3,
4]. Proteinuria can, however, also be produced in complement-
depleted [5] or neutrophil-depleted [31rabbits. Further evidence
of complement-independent injury has been obtained in rats
given avian [30, 311 or guinea pig [32, 33] anti-GBM antibody
and in guinea pigs given sheep anti-GBM antibody [9, 10].
While a role for a variety of other mediators of inflammation has
been postulated in these complement-independent models,
none has thus far been shown to be operative [8]. The ability of
a nephrotoxic antibody alone to injure the glomerular filter
independently of other mediators has been demonstrated in one
study [13], but the mechanism by which this effect occurs is
unclear.
Although the model described in our study resembles com-
plement-independent nephrotoxic nephritis with respect to the
immediate and transient nature of the proteinuria and the lack
of participation of complement, this model is clearly different
from nephrotoxic nephritis with respect to both the nature and
distribution of the antigen involved and also the antibody
mechanisms which mediate the proteinuria. Glomerular capil-
lary wall, immune deposits produced by heterologous anti-
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FxIA IgG are characteristically granular by IF [20, 29, 34] and
associated with subepithelial, electron-dense deposits [20, 29].
The distribution of these deposits, together with recent informa-
tion that they form in situ [20, 34], suggests that the putative
antigen is similarly located. This observation contrasts with the
linear, fluorescent GBM deposits which are the hallmark of
anti-GBM nephritis [351 and in which the antigen appears to be
more widely distributed in the GBM [351. The distinction was
further illustrated by studies in which extensive absorption of
anti-FxIA with solubilized GBM (sufficient to remove nephro-
toxic activity from anti-GBM antiserum) failed to substantially
alter its ability to form granular, glomerular capillary wall
deposits in vivo [20]. While the glomerular deposits seen at 3 hr
by IF in proteinuric rats given the F(ab')2 and Fab' antibody in
our study were minimal and were not clearly granular, and
electron-dense deposits were not yet present, the deposits were
certainly not the ribbon-like, linear deposits of nephrotoxic
nephritis. By 24 hr, distinct granularity was evident and accom-
panied by subepithelial deposits which were similar to those
seen in the membranous lesion induced by native anti-FxIA
IgG. Hence it seems likely that increased permeability induced
by anti-FxIA antibody fragments was secondary to in situ
deposit formation involving fixed antigens in the outer capillary
wall at a site different to that implicated in anti-GBM antibody
nephritis.
Important differences between the model described here and
complement-independent, nephrotoxic nephritis also exist with
respect to the characteristics of the antibody required to
produce proteinuria and, by inference, probably also with
respect to the mechanisms involved. In nephrotoxic nephritis,
neither of the univalent fragments, Fab or Fab', of anti-GBM
antibody were capable of altering glomerular permeability [8.
9], despite renal binding greatly in excess of the amount of
intact IgG which causes massive proteinuria [81. F(ab')2, anti-
GBM antibody has a nephritogenic potential equivalent to that
of intact IgG in a complement-independent model [9, 37]. These
studies have been interpreted to indicate that both antigen-
combining sites of IgG are required for glonierular injury to be
induced by the anti-GBM antibody. In contrast, in the model
described here, both Fab' and F(ab')2 antibodies induced
immediate proteinuria while the binding of equivalent quantities
of intact lgG failed to do so. Thus, not only can the change in
glomerular permeability effected by these antibody fragments
be induced by a monovalent as well as a divalent antibody, but
the capacity of these reagents to mediate injury is markedly
enhanced compared to that of intact IgG. This observation
suggests that the glomerular binding of these antibody frag-
ments is causing a change in permeability by a mechanism that
differs from that of the IgG anti-GBM antibody and is also
different from the mechanism by which intact IgG anti-FxlA
antibody induces proteinuria at 5 days, a process which re-
quires much greater amounts of antibody deposition [20] as well
as the participation of complement [7].
The complement-independent mechanisms by which the anti-
body fragments produce increased protein excretion in this
model are unclear. Several possibilities merit consideration.
One possibility is that the proteinuria found in our study was
not due to increased glomerular permeability but instead re-
flected either the glomerular filtration of injected antibody
fragments or decreased reabsorption of filtered protein induced
by the observed binding of these fragments to the proximal
tubular brush border. The former is excluded by the demonstra-
tion that significant proteinuria did not follow an injection of
equivalent quantities of nonantibody IgG fragments. Also,
when antibody fragments were measured in the urine samples
of proteinuric animals, they accounted for less than 10% of the
total protein present. For the following reasons, it is also
unlikely that proteinuria resulted purely from immunologic
impairment of proximal, tubular reabsorption of normally fil-
tered albumin. Firstly, protein excreted by rats given antibody
fragments constituted a relatively high proportion of albumin
and high molecular weight globulins as compared to the urine
composition of normal rats. These features are more consistent
with proteinuria of glomerular origin than with a reabsorptive
disorder in which proteins of a lower molecular weight predomi-
nate [38, 39]. Secondly, tubular albumin reabsorption would
have to be reduced to zero from a normal value of about 90%
[38] to account for the amount of albumin excreted by rats given
the F(ab')2 antibody in our study [38, 40, 41]. Such a degree of
functional impairment seems highly improbable in the absence
of other evidence of proximal tubular injury. There is experi-
mental evidence that an intact IgG antibody deposited on the
proximal tubular brush border can alter epithelial transport [42]
and may be associated with both morphologic and functional
changes in proximal tubules [43, 44J. However, these latter
changes appear to require complement deposition as well, a
finding which was absent in our study. Although we have done
preliminary studies of proximal tubular function which suggest
that the reabsorption of glucose, phosphate, and uric acid are
not altered in this model, studies to directly measure glomerular
permeability and tubular transport of protein are required to
conclusively exclude any contribution of proximal tubular
dysfunction to the observed proteinuria. The presence of focal,
glomerular, podocyte effacement in proteinuric animals at 24 hr
further suggests that the proteinuria in this model is predomi-
nantly glomerular in origin.
Several complement-independent antibody effects on glomer-
ular permeability have been described. In the autologous phase
of nephrotoxic nephritis in rabbits, proteinuria and a severe
proliferative lesion can be mediated by neutrophils indepen-
dently of complement, although the Fc piece of the IgG
molecule is required [5, 6]. In our model, however, no neutro-
phils or other histologic changes were seen in glomeruli, and the
Fc piece is absent. A reduced renal plasma flow and filtration
rate are characteristic of the period immediately following the
administration of nephrotoxic serum to rats [451. Such condi-
tions have been shown by physiologic studies to be associated
with an increased fractional clearance of macromolecules [461,
and by morphologic studies, to give rise to an increased
penetration of serum proteins through the glomerular capillary
wall [47]. Although it is possible that similar hemodynamic
alterations may have occurred in our study and given rise to
transient proteinuria, it seems unlikely that only rats given anti-
Fx1A antibody fragments would have been so affected while
those given the intact IgG antibody were spared. It is also
necessary to consider the possibility that the normal barrier to
macromolecular filtration imposed by the fixed-negative charge
on the capillary wall [48, 49] may have been neutralized in this
model, as may occur in the proteinuric, glomerular lesion
induced by aminonucleoside of puromycin [50—54] and in the
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autologous phase of nephrotoxic nephritis in rats [491. The
remarkable correspondence between the distribution of depos-
its in this model and glomerular anionic sites demonstrated by
others using positively charged, tracer molecules makes a role
for charge alterations in producing proteinuria in this model
particularly attractive [53, 54]. While proteinuric rats in this
study did not have reduced colloidal iron-staining for glomeru-
lar polyanion, clearance or tracer studies using positively and
negatively charged macromolecules would be necessary to fully
elucidate the role of the charge barrier.
The actual site of interaction responsible for glomerular
injury in this model is open to speculation. Recent studies have
shown reactivity of anti-FxlA with an antigen residing in the
endothelial region of the capillary wall. This reactivity was
apparent during the first 24 hr after antibody administration and
not thereafter [55]. While this phenomenon might account for
the transience of proteinuria found in our study, it would not
explain its absence in rats given intact lgG antibody. It would
be anticipated that IgG would be as likely to injure the endothe-
hal region as the antibody fragments. Alternatively, the devel-
opment of subepithelial deposits in F(ab')2, antibody-injected
rats and the observation that antibody fragments appear to have
more immediate access to the antigen than the larger intact
molecule [14], suggests that the reaction responsible for pro-
teinuria occurred at a more distal site in the capillary wall.
It is unlikely that F(ab')2 or Fab' antibodies play any role in
naturally occurring glomerular disease in man. Nevertheless,
the ability of these antibody fragments to markedly change
glomerular permeability by reacting with and presumably alter-
ing components of the capillary wall without producing detect-
able histologic changes may have implications for the under-
standing of proteinuria in human diseases with similar features.
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